These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7660645)

  • 41. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
    Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
    Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
    [No Abstract]   [Full Text] [Related]  

  • 44. Haemolytic disease of the newborn due to anti-Ce.
    Malde R; Stanworth S; Patel S; Knight R
    Transfus Med; 2000 Dec; 10(4):305-6. PubMed ID: 11123814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Pregnancy-Induced Anti-HLA Antibodies Using Luminex Platform.
    Vilches M; Nieto A
    Transplant Proc; 2015 Nov; 47(9):2608-10. PubMed ID: 26680049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can serological methods help distinguish between prophylactic and alloimmune anti-D?
    Irving C; Crennan M; Vanniasinkam T
    Transfus Med; 2017 Oct; 27 Suppl 5():362-368. PubMed ID: 28508562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
    Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-D concentration in mother and child in haemolytic disease of the newborn.
    Hughes-Jones NC; Ivona M; Ellis J; Walker W
    Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
    Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
    Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies.
    Hoekstra FM; Witvliet M; Knoop CY; Wassenaar C; Bogers AJ; Weimar W; Claas FH
    Ann Thorac Surg; 1998 Dec; 66(6):2022-6. PubMed ID: 9930487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Murine monoclonal antibodies and human alloantisera specific for HLA inhibit monocyte phagocytosis of anti-D-sensitized human red blood cells.
    Neppert J; Marquard F; Mueller-Eckhardt C
    Eur J Immunol; 1985 Jun; 15(6):559-63. PubMed ID: 3924629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies.
    Neppert J; Kissel K
    Lancet; 1992 Jun; 339(8807):1481. PubMed ID: 1351152
    [No Abstract]   [Full Text] [Related]  

  • 60. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.